1 / 61

Brazil OTC Pharmaceutical Market Analysis

This report presents a strategic analysis of Brazil Over The Counter (OTC) Pharmaceuticals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Brazil OTC Pharmaceuticals Market, offering unmatched value, accuracy, and expert insights. mail us at: info@insights10.com

Insights4
Download Presentation

Brazil OTC Pharmaceutical Market Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A sample report on Brazil OTC Pharmaceuticals Market Analysis Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2021 – 2030F) www.insights10.com

  2. This report presents a strategic analysis of the Brazil OTC Pharmaceutical market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, characteristics, main players, trends and insights, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Brazil OTC Pharmaceutical market, and offers unmatched value, accuracy, and expert insights

  3. • Market Overview • Growth Drivers & Restraints • Major Types of OTC Drugs • Market Segmentation • Major Products Market Share • Competitive Landscape • Key Company Profiles • Healthcare Policies & Regulatory Framework • Notable Deals • Strategic Recommendations Table of Contents

  4. Table of Contents 1. Brazil OTC pharmaceuticals market overview………………………..………………………………………………………………………….7 1.1 Market size and forecast 2. Market growth drivers and restraints ………………………………………………………..……………..….…………………………………9 2.1 Market growth Drivers 2.1.1 Accessibility of OTC drugs 2.1.2 Increasing Product Innovation 2.1.3 Switching of Rx Drugs to OTC 2.2 Market Restrains 2.2.1 Irrational use of medicines due to self-diagnosis / misdiagnosis 2.2.2 Drug abuse, possibilities of drug addiction 3. Major types of OTC drugs…………..…………….….……..………………………………….…………………………………………........….15 3.1 Analgesics 3.2 Cough, Cold and Flu Products 3.3 Vitamins and Minerals 3.4 Skincare Products 3.8 Sleep Aid Products 3.5 Anti Allergic Drugs (Antihistamines) 3.6 Gastrointestinal Products 3.7 Ophthalmic Products 4 4 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  5. Table of Contents (continued) 4. OTC pharmaceuticals market segmentation……………………………………….…………....………………....…………………........….….18 4.1 By Product Type 4.2 By Formulation 4.3 By Distribution Channel 5. Major products market share……………………………………………………….………………...…….……………………………..…………23 5.1 Market analysis, insights and forecast - By revenue 6. Competitive Landscape…………………………………………………………………………………………………….……………………...….25 6.1 Major players 6.2 Key Players by Revenue Growth and Market Share 7. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ….…………………………….…............27 7.1 Abbott Laboratories 7.2 Natura &Co 7.3 Sanofi-Aventis SA 7.4 Glenmark Pharmaceuticals Ltd. 7.6 Takeda Pharmaceuticals 7.5 Johnson & Johnson Services Inc 7.6 LIBBS Farmaceutica Ltd 7.7 GlaxoSmithKline plc 5 5 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  6. Table of Contents (continued) 8. Healthcare policies and regulatory landscape………………………………….………………………………………………………...………36 8.1 Policy changes and Reimbursement scenario 9. Notable Deals…………………………………………………………………………………………….……………………………………………..39 9.1 Notable recent deals and partnerships 10. Strategic recommendations…………………………………………………………………………………………………..………..……….…..42 6 6 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  7. Brazil OTC Pharmaceutical Market Analysis 1. Overview

  8. Brazil OTC Pharmaceuticals market analysis (Current and Forecast) Key Analysis Brazil OTC Pharmaceuticals Market Size (Bn) 2021-2030F xx Brazil OTC Pharmaceuticals Market size stood at around US$ 3.381 Bn in 2021 and is projected to reach US$ XX Bn by 2030, exhibiting a CAGR of 5.7% during the forecast period ▪ The market's largest segment is the segment Analgesics with a market volume of US$1.038 Bn in 2022 ▪ In the OTC Pharmaceuticals market, 24.2% of total revenue will be generated through online sales by 2022 ▪ $3.381 Sample 2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F 8 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  9. Brazil OTC Pharmaceutical Market Analysis 2. Growth Drivers & Restraints

  10. 2. Market Growth Drivers and Restrains Switching of Rx Drugs to OTC Accessibility of OTC drugs Increasing Product Innovation Irrational use of medicines due to self-diagnosis / misdiagnosis Drug abuse, possibilities of drug addiction 10 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  11. 2.1 Market Growth Drivers 2.1.1 Accessibility of OTC drugs New channels of accessibility in emerging markets in retail outlets, supermarkets are contributing to the growth of the Brazil OTC pharmaceuticals market in the emerging economies Allowing some medications, under specific circumstances, to be available without the necessity of seeing a prescriber may allow prescribers to spend more time with seriously ill patients. The FDA is considering allowing the establishment of some medications (that are now available by prescription) to be available OTC, after use of specific electronic diagnostic measures or algorithms; or after consultation with a pharmacist; or by other additional means Sample 11 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  12. Market Growth Drivers (continued) 2.1.2 Product Innovations Product innovation, high penetration in emerging markets, a favorable regulatory framework, and the trend for pharmaceutical companies to shift from prescription to OTC are the growth drivers of the OTC market of Brazil With technological advancements and product innovation, SMEs are expanding their market presence by introducing new products at lower prices Sample 12 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  13. Market Growth Drivers (continued) 2.1.3 Switching of Rx Drugs to OTC Several companies have been opting for several innovative marketing strategies, to capture a market share as high as possible. Companies are using various strategies to switch to Rx drugs to OTC drugs Key industry players are involved in R&D to develop and market new OTC drugs for various health conditions. Hence patients are switching to new OTC drugs instead of Rx drug which will leading the OTC market in the Brazil Sample Sample 13 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  14. 2.2 Market Restraints 2.2.2 Drug abuse, possibilities of drug addiction 2.2.1 Probability of Substance Abuse Consumption of wrong medication due to incorrect self-diagnosis or misdiagnosis may lead to severe complications and is one of the key factor that may hinder the market growth ▪ All OTC medication carries risk, primarily risk of tolerance and dependence by OTC painkillers ▪ High and more frequent doses of OTC drugs can lead to phycological dependence ▪ Many OTC cold and cough products have led to medication errors and cause adverse effects on the patient’s body ▪ Drug abuse of antihistamines, sleep aids, caffeine, ephedrine, pseudoephedrine, antitussives and expectorants, dextromethorphan, laxatives, anabolic steroids, and sildenafil by teenagers is one of the major challenge ▪ Sample 14 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  15. Brazil OTC Pharmaceutical Market Analysis 3. Major OTC Drugs

  16. Major OTC Drugs 4.2 Cough, Cold and Flu Products There are lots of different cold and cough medicines, and they do different things: Nasal decongestants - unclog a stuffy nose Cough suppressants - quiet a cough Expectorants - loosen mucus in your lungs so you can cough it up. Antihistamines - stop runny noses and sneezing 4.3 Vitamins and Minerals 4.4 Skincare Products 4.1 Analgesics OTC dermatology drugs are an accepted treatment for many common medical problems, including musculoskeletal pain, headaches, cold symptoms, allergies, heartburn, and dermatitis ▪ Vitamin and mineral rich supplements have medicinal properties which offer healing benefits apart from fulfilling daily required nutrients. It helps in building a strong immune system against common diseases ▪ Analgesics are medications that relieve pain ▪ ▪ Unlike medications used for anesthesia during surgery, analgesics don't turn off nerves, change the ability to sense your surroundings or alter consciousness ▪ ▪ ▪ ▪ 16 16 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  17. Major OTC Drugs 4.5 Anti Allergic Drugs 4.6 Gastrointestinal Products 4.7 Ophthalmic Products 4.8 Sleep Aid Products Most over-the-counter (OTC) ophthalmic drugs contain humectants (substances that help retain moisture), lubricants, and electrolytes, such as potassium which help in providing extra moisture to the eyes and can be used as per the directions given ▪ Sample Sample Sample 17 17 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  18. Brazil OTC Pharmaceutical Market Analysis 4. Market Segmentation 18

  19. Market Segmentation OTC Market Segmentation By Distribution Channel By Product Type By Formulation Analgesics Cough, Cold and Flu , Anti Allergic Products Pharmacies Tablets (Oral) Vitamins and Minerals Supermarkets Liquids (Oral) Dermatological Products Convenience Stores Ointments (Topical) Online Stores Gastrointestinal Products Sprays (Topical) Sleep Aid Products Ophthalmic Products Weight Loss/Diet Products 19 19 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  20. 4.1 OTC Pharmaceuticals Market Segmentation: By Product Type Key Insights Brazil OTC Market Share by Product Type 2022 By Product type Brazil OTC drugs segments the market intoAnalgesics Cough, Cold and Flu Products, Vitamins and Minerals, Dermatological Products, Gastrointestinal Products, Ophthalmic Products, SleepAid Products, WeightLoss/Diet Products, Others ▪ Sample Vitamins and Minerals Analgesics,Cough & Cold,AntiAllergic GastrointestinalProducts Dermatological Products Ophthalmic Products SleepAid Products WeightLoss/DietProducts 20 20 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  21. 4.2 OTC Pharmaceuticals Market Segmentation: By Formulation Key Insights Brazil OTC Market Share By Formulation 2022 Brazil OTC Market is segmented into Tablets, Liquids, Ointments, and Sprays by formulation ▪ Sample Tablets Liquids Ointments Corticosteroids 21 21 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  22. 4.3 OTC Pharmaceuticals Market Segmentation: By Distribution Channels Key Insights Brazil OTC Market Share by Distribution Channel 2022 The Brazil OTC Market is segmented into Online Pharmacies, Supermarkets, Convenience Stores, and Online Stores by the Distribution Channels ▪ Hospitals remain the primary point of access for healthcare services, and the distribution of consumer health products is only permitted through pharmacies ▪ Pharmacies Supermarkets ConvenienceStores Online Stores 22 22 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  23. Brazil OTC Pharmaceutical Market Analysis 5. Major Product Market Share 23

  24. 5.1 Market Analysis, Insights and Forecast- By Major Brands Key Insights Market Analysis for Major OTC Pharmaceuticals Brands (2022 Get full report for access Brand 1 Brand 2 Brand 3 Brand 4 Brand 5 24 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  25. Brazil OTC Pharmaceutical Market Analysis 6. Competitive Landscape

  26. 6.1 Competitive Landscape: Key Players Revenue (Current and Forecast) Major Market Revenue of Top Companies in Market ($Mn) 2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Abbott Laboratories $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx Natura &Co $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx Sanofi-Aventis SA $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx Glenmark Pharmaceuticals Ltd. $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx Johnson & Johnson Services Inc $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx LIBBS Farmaceutica Ltd $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx GlaxoSmithKline plc $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx Takeda Pharmaceuticals $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx 26 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  27. Brazil OTC Pharmaceutical Market Analysis 7. Key Company Profiles

  28. 7.1 Abbott Laboratories Company Overview Company at a Glance Company Name: Abbott Laboratories Year of Establishment: 1888 Headquarter: Chicago, Illinois, United States Total Revenue: $XX Bn Website: http://www.abbott.com/ Sample 28 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  29. 7.2 Natura &Co Company Overview Company at a Glance Company Name: Natura &Co Year of Establishment: 1969 Headquarter: São Paulo, Brazil Total Revenue: $XX Bn Website: https://www.naturaeco.com/ Sample 29 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  30. 7.3 Sanofi Company Overview Company at a Glance Company Name: Sanofi Year of Establishment: 2004 Headquarter: Paris, France Total Revenue: $XX Bn Website: http://www.sanofi.com/ Sample 30 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  31. 7.4 Glenmark Pharmaceuticals Ltd. Company Overview Company at a Glance Company Name: Glenmark Pharmaceuticals Ltd. Year of Establishment: 1977 Headquarter: Mumbai, India Total Revenue: $XX Bn Website: glenmarkpharma.com Sample 31 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  32. 7.5 Johnson & Johnson Company Overview Company at a Glance Company Name: Johnson & Johnson Year of Establishment: 1886 Headquarter: New Brunswick, New Jersey, United States Total Revenue: $XX Bn Website: www.jnj.com Sample 32 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  33. 7.6 LIBBS Farmaceutica Ltd Company Overview Company at a Glance Company Name: LIBBS Farmaceutica Ltd Year of Establishment: 1958 Headquarter: São Paulo, State of São Paulo, Brazil Total Revenue: $xx Bn Website: www.libbs.com.br/ Sample 33 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  34. 7.7 GlaxoSmithKline plc Company Overview Company at a Glance Company Name: GlaxoSmithKline plc Year of Establishment: 2000 Headquarter: Brentford, United Kingdom Total Revenue: $XX Bn Website: www.gsk.com Sample 34 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  35. 7.8 Takeda Pharmaceuticals Company Overview Company at a Glance Company Name: Takeda Pharmaceuticals Year of Establishment: 1781 Headquarter: Tokyo, Japan Total Revenue: $XX Bn Website: www.takeda.com/ Sample 35 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  36. Brazil OTC Pharmaceutical Market Analysis 8. Healthcare Policy and Regulatory Landscape

  37. 8.1 Regulatory Landscape: Healthcare Policy The Brazilian Health Surveillance Agency (ANVISA) published Collegiate Board Resolution 98/2016. The Resolution establishes new rules for the inclusion of certain drugs as over-the-counter drugs (OTCs) ▪ The new rules allow the inclusion of new drugs to the list of OTCs, setting out seven conditions concerning the following: ▪ Time of marketing • Safety • Identifiable symptoms • Time of use • Management by the patient • Low potential of risk • Low addiction • The Resolution seeks to provide clear rules to pharmaceutical companies that wish to submit applications for the reclassification of their drugs as OTCs before ANVISA. A number of procedures must be followed after ANVISA's classification of the drug as an OTC: for example, the marketing authorisation holder must submit a "request for sale category change" and a "notification for leaflet information change“ ▪ Get full report for access 37 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  38. Successful market access Entering the pharmaceutical market in Brazil is complex and requires long-term planning. First, the company must determine which commercial strategy it will adopt in Brazil (import or manufacture of drugs) ▪ Then, it must establish itself in Brazil by acquiring and adapting to a location or establishing a partnership with a competent local company ▪ The next step is to obtain sanitary licenses prior to the activity and mandatory before ANVISA and Local Sanitary Surveillance, such as an Operating Permit, Local License and Certificates of Good Practice ▪ In possession of these authorizations, the company may then apply for the MA of the drug. Once granted the MA of the drug by ANVISA, the company must then request the drug capped price before COUNCIL OF MINISTERS of the DRUG MARKET REGULATION CHAMBER (CMED) .With the fixing of the price, the company may sell the product on the Brazilian market ▪ Technical and legal assistance is recommended during the entire process of establishing the company in Brazil, in particular, to adapt physical facilities, prepare technical documents, and maintain a good relationship with the authorities, while always abiding by legislation and remaining helpful and proactive ▪ 38 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  39. Brazil OTC Pharmaceutical Market Analysis 9. Notable Deals

  40. Glenmark Pharmaceuticals Ltd has acquired the approved generic versions of certain over-the-counter drugs from Wockhardt Ltd Glenmark Pharmaceuticals Ltd Wockhardt Ltd In June 2022, Glenmark Pharmaceuticals Ltd has acquired the approved generic versions of certain over-the-counter drugs from Wockhardt Ltd in the United States. The acquisition by the company’s fully-owned subsidiary Glenmark Pharmaceuticals Inc, includes the approved abbreviated new drug applications (ANDAs) for famotidine tablets, 10 mg and 20 mg used to treat and prevent ulcers in the stomach and intestine Sample 40 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  41. GSK reaches agreement with Novartis to acquire full ownership of consumer healthcare business Novartis GlaxoSmithKline plc Sample Sample Sample 41 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  42. Brazil OTC Pharmaceutical Market Analysis 10. Conclusion

  43. Strategic Recommendations Personalized medicine for osteoarthritis OTC drugs are characterized by strong brand loyalty compared to general consumer goods, retailers with powerful sales capabilities are expected to strengthen the market presence of their private labels in the future ▪ Companies with solid sales capabilities and expertise could play a part in expanding the sales channels of OTC drugs that have strong brand recognition. With the influence of online pharmacies spreading, even the majors behind leading brands are rushing to strengthen their sales capabilities. ▪ Companies in other industries will likely discover new business opportunities in the unique characteristics of OTC drugs and trends in the industry, which is yielding new business opportunities ▪ Get full report for access 43 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential

  44. Methodology & Scope

  45. Research Methodology Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources For forecasting, the following parameters are considered: ❑ Market drivers and restraints along with their current and expected impacts ❑ Technological scenario and expected developments ❑ End use industry trends and dynamics ❑ Trends in the consumer behavior ❑ Regulatory scenario and expected developments ❑ Current capacity and expected capacity additions up to 2030 We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time- sensitive, reflecting the most recent value and volume of the market across regions All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs) Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn) ▪ ▪ ▪ ▪ ▪ ▪ ▪ 45 A Sample Report on Brazil OTC Pharmaceutical Market Analysis I Confidential

  46. Analysis Methodology Our Analysis Methodology involves three critical stages: Market Data Analysis & Statistical Model Interpretation & Presentation Data Collection Analysis & Interpretation Market Trends Secondary Research Market Sizing & Analysis Insights Primary Research Presentation & Reporting Data Triangulation & Validation 46 A Sample Report on Brazil OTC Pharmaceutical Market Analysis I Confidential

  47. Data Triangulation & Data Validation Top Down Approach Final Market Size Final Market size break up to rest of segmentation Validation from Primary Interview Arriving at market size of each segment Summarization of revenue generated from companies to arrive at total market size Validation from Primary Interview Revenue generated by products & services offered by companies Final Summary Bottom Up Approach 47 A Sample Report on Brazil OTC Pharmaceutical Market Analysis I Confidential

  48. Key Benefits for Stakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors 48 A Sample Report on Brazil OTC Pharmaceutical Market Analysis I Confidential

  49. Time Frame Report Attribute Details Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Base Year for Estimation 2021 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Company Profiles, Competitive Landscape, Regulatory Landscape, Future Opportunities Report Coverage Report Customization (5 working days) with purchase. We will provide you with data that is currently not a part of our scope as a part of customization Customized Report Forecast Period 2022- 2030 Pricing and purchase options Avail customized purchase options to meet your exact research needs

  50. What kind of Data is Presented in this Report? This report presents data, which is: Expert-verified Real Comprehensive Easy to read Reliable The data is prepared by a team of highly qualified & experienced research analysts & vetted by our local associates Covers everything you would need to know about the market including market size, competitive analysis & much more You do not have to be a market expert to understand what really is happening on the market and how it works Allowing you to confidently make smarter business and strategic decisions The report is prepared using a proven methodology and insightful research www.insights10.com

More Related